| Petros Pharmaceuticals, Inc. (PTPI) |
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 |
| Balance Sheet Date | | | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Common Stock | | | | | 0.06$ | 0.07$ | 0.39$ | 0.36$ | 0.47$ | 1.50$ | 1.35$ | 1.54$ | 2.02$ | 1.38$ | 2.28$ | 0.60$ | 0.82$ | 1.53$ | 3.33$ | 1.92$ | 3.14$ | 3.65$ | 4.43$ | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | | | | | 1,966,201$ | 3,746,333$ | 3,870,748$ | 3,448,797$ | 3,290,092$ | 3,301,604$ | 2,971,443$ | 3,254,898$ | 4,269,411$ | 28,577,073$ | 47,214,295$ | 12,512,189$ | 16,961,473$ | 31,647,626$ | 43,724,465$ | 18,867,070$ | 30,766,540$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | | | | | (47.52%) | (3.21%) | 12.24% | 4.82% | (.35%) | 11.11% | (8.71%) | (23.76%) | (85.06%) | (39.47%) | 277.35% | (26.23%) | (46.41%) | (27.62%) | 131.75% | (38.68%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | | | | | (40.24%) | 13.47% | 30.27% | 5.96% | (22.94%) | (88.45%) | (93.71%) | (73.99%) | (74.83%) | (9.70%) | 7.98% | (33.68%) | (44.87%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 42,372,260 | | 42,284,502 | 42,284,502 | 42,284,502 | 2,052,762 | 421,124 | 10,014,872 | 9,297,538 | 6,881,864 | 2,991,377 | 2,119,620 | 2,119,620 | 2,088,698 | 2,079,387 | 20,708,024 | 20,684,723 | 20,684,723 | 2,068,472 | 9,826,599 | 9,826,599 | 9,798,261 | 9,707,655 | 3,434,551 | 3,434,551 | 4,949,610 | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | | | .00% | .00% | 1,959.88% | 387.45% | (95.80%) | 7.72% | 35.10% | 130.06% | 41.13% | .00% | 1.48% | .45% | (89.96%) | .11% | .00% | 900.00% | (78.95%) | .00% | .29% | .93% | 182.65% | .00% | (30.61%) | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | .21% | | 9,940.87% | 322.22% | 354.79% | (70.17%) | (85.92%) | 372.48% | 338.64% | 229.48% | 43.86% | (89.76%) | (89.75%) | (89.90%) | .53% | 110.73% | 110.50% | 111.11% | (78.69%) | 186.11% | 186.11% | 97.96% | | | | | | | | | | | | | | | | | | | | | | | | | | | |